To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ASPHTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
656 representative clones for gene ASPH back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DC425616   .a 1 to 506 1 to 506   tiling clone,   506/506
(100 %)
2 diff
(99.7 %id)
CB268742 adipose .a 63 to 194 1 to 132       132/132
(100 %)
0 diff
(100 %id)
NM_004318.3   .a 230 to 5578 1 to 5349 exact RefSeq,   5349/5349
(100 %)
0 diff
(100 %id)
CR996516 T-Lymphocytes .a 230 to 818 1 to 589       589/589
(100 %)
2 diff
(99.7 %id)
BP417189 small intestine .a 273 to 648 1 to 376     Submitted on the opposite strand 376/376
(100 %)
0 diff
(100 %id)
DB210659 trachea .a 277 to 847 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA041255 bladder .a 278 to 837 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA310276 hippocampus .a 278 to 855 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
DA652595   .a 279 to 852 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
DA659879   .a 279 to 853 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DA661625   .a 279 to 867 2 to 590   capped   589/589
(100 %)
2 diff
(99.7 %id)
DA856352 placenta .a 279 to 867 2 to 590   capped   589/589
(100 %)
2 diff
(99.7 %id)
BM462707 melanotic melanoma, skin .a 283 to 1063 1 to 795   AAA   795/994
(79 %)
19 diff
(98.1 %id)
DA659557   .a 283 to 858 2 to 577   capped   576/576
(100 %)
3 diff
(99.5 %id)
DA020312   .a 284 to 853 2 to 573   capped   572/572
(100 %)
4 diff
(99.4 %id)
DB228312 trachea .a 285 to 859 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DB235287 trachea .a 285 to 861 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
DB265199 uterus .a 285 to 864 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
DA549990   .a 293 to 866 2 to 575   capped   574/574
(100 %)
3 diff
(99.5 %id)
DA422422 cervix .a 298 to 869 2 to 573   capped   572/572
(100 %)
3 diff
(99.5 %id)
CN368823 embryonic stem cells, cell lines H1, H7, andH9 .a 303 to 1071 1 to 770       770/770
(100 %)
4 diff
(99.5 %id)
CV571131 cornea, eye .a 311 to 910 1 to 600       600/600
(100 %)
2 diff
(99.7 %id)
DA039598 bladder .a 315 to 885 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BE876059 large cell carcinoma, undifferentiated, lung .a 320 to 1115 1 to 796   available from MGC,   794/1048
(75 %)
35 diff
(96.7 %id)
AL701528 human skeletal muscle .a 321 to 646 1 to 326       326/326
(100 %)
0 diff
(100 %id)
DA478757   .a 322 to 908 2 to 591   capped   590/590
(100 %)
5 diff
(99.2 %id)
DB096287 testis .a 322 to 868 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DB239604 trachea .a 322 to 917 2 to 597   capped   596/596
(100 %)
1 diff
(99.9 %id)
DB241184 trachea .a 322 to 919 2 to 599   capped   598/598
(100 %)
2 diff
(99.7 %id)
DB466574 hippocampus .a 329 to 1060 1 to 732       732/732
(100 %)
7 diff
(99.1 %id)
BJ994672 hepatoblastoma .a 329 to 792 1 to 464       464/469
(98 %)
1 diff
(99.8 %id)
DA025167   .a 330 to 901 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DB223754 trachea .a 330 to 798 2 to 470   capped   469/469
(100 %)
0 diff
(100 %id)
DA439915 tongue, tumor tissue .a 331 to 912 2 to 583   capped   582/582
(100 %)
2 diff
(99.7 %id)
DA567775   .a 331 to 786 2 to 457   capped   456/456
(100 %)
0 diff
(100 %id)
DB097173 testis .a 331 to 926 2 to 597   tiling clone, capped   596/596
(100 %)
0 diff
(100 %id)
DB013981 esophageal, tumor tissue .a 338 to 909 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DA582295 lung .a 339 to 894 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA155424 amygdala .a 341 to 911 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
CN481475 eye .a 352 to 961 1 to 610       610/610
(100 %)
2 diff
(99.7 %id)
BU838423 dorsal root ganglia .a 352 to 1150 1 to 801       801/930
(86 %)
14 diff
(98.5 %id)
CN481470 eye .a 357 to 962 1 to 606       606/606
(100 %)
3 diff
(99.6 %id)
DA027319   .a 363 to 939 2 to 578   capped   577/577
(100 %)
4 diff
(99.4 %id)
DA651142   .a 363 to 946 2 to 586   capped   585/585
(100 %)
3 diff
(99.5 %id)
DA652583   .a 363 to 943 2 to 583   capped   582/582
(100 %)
3 diff
(99.5 %id)
DB220339 trachea .a 363 to 936 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DA395147 thalamus .a 365 to 952 2 to 590   capped   589/589
(100 %)
3 diff
(99.5 %id)
DA457967 tongue, tumor tissue .a 365 to 936 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DA654087   .a 365 to 962 2 to 600   capped   599/599
(100 %)
3 diff
(99.5 %id)
DA862766 placenta .a 365 to 937 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
CN368833 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 367 to 757 1 to 391       391/391
(100 %)
0 diff
(100 %id)
BI333062 cervical carcinoma cell line, cervix .a 376 to 1095 1 to 721       721/721
(100 %)
3 diff
(99.6 %id)
BX403636 placenta .a 379 to 1386 1 to 1006       1006/1011
(99 %)
9 diff
(99.2 %id)
CN368819 embryonic stem cells, cell lines H1, H7, andH9 .a 386 to 684 1 to 299       299/299
(100 %)
0 diff
(100 %id)
DA884755   .a 418 to 991 2 to 575   capped   574/574
(100 %)
4 diff
(99.4 %id)
EU718494   .a 422 to 1475 1 to 1054       1054/1249
(84 %)
5 diff
(99.6 %id)
U03109   .a 422 to 2873 1 to 2449 Y565I W575C W576G T577P P578K ...     2449/2449
(100 %)
10 diff
(99.6 %id)
BU502544 carcinoma, cell line, Prostate .a 449 to 1148 1 to 703       701/959
(73 %)
7 diff
(99.3 %id)
S83325   .a 488 to 2811 1 to 2324 K709R tiling clone,   2324/2324
(100 %)
2 diff
(100.0 %id)
DA024588   .a 612 to 1190 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
CV574249 cornea, eye .a 637 to 1270 1 to 634       634/634
(100 %)
0 diff
(100 %id)
DA454228 tongue, tumor tissue .a 731 to 1309 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
AL120973 melanoma (MeWo cell line) .a 751 to 1174 1 to 424       424/424
(100 %)
0 diff
(100 %id)
DA287068 corpus callosum .a 779 to 1355 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
CD643948 Embryonic Stem cells .a 891 to 1595 12 to 711       702/765
(91 %)
13 diff
(98.4 %id)
CV575591 cornea, eye .a 892 to 1527 1 to 636       636/636
(100 %)
0 diff
(100 %id)
DB212399 trachea .a 1119 to 1679 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BP336604 coronary artery .a 1253 to 1855 1 to 603       603/603
(100 %)
1 diff
(99.9 %id)
DB063753 testis .a 1312 to 1849 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DA109134 cerebellum .a 1344 to 1915 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BM806632 melanotic melanoma, skin .a 1352 to 2269 1 to 917       917/1050
(87 %)
13 diff
(98.8 %id)
BX479249   .a 1413 to 1929 1 to 517       517/517
(100 %)
0 diff
(100 %id)
DA410897 thalamus .a 1454 to 2008 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DB217265 trachea .a 1509 to 2072 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB074482 testis .a 1513 to 2053 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DA019008   .a 1516 to 2081 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA442940 tongue, tumor tissue .a 1518 to 2093 2 to 577   capped   576/576
(100 %)
3 diff
(99.5 %id)
CN274513 embryonic stem cells, DMSO-treated H9 cellline .a 1546 to 2000 1 to 455       455/455
(100 %)
0 diff
(100 %id)
BP364957 lung .a 1568 to 2151 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA861275 placenta .a 1589 to 2164 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA858525 placenta .a 1591 to 2142 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BP266690 thyroid .a 1601 to 2181 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
CN258117 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1650 to 2240 1 to 589       589/589
(100 %)
2 diff
(99.7 %id)
FN099127 breast carcinoma .a 1676 to 1771 97 to 1     Submitted on the opposite strand 97/97
(100 %)
1 diff
(99.0 %id)
BM790814 stomach .a 1706 to 2394 1 to 689       689/689
(100 %)
0 diff
(100 %id)
AW996828 breast_normal .a 1824 to 2472 648 to 1     Submitted on the opposite strand 648/651
(99 %)
3 diff
(99.6 %id)
BP328261 rectum .a 1838 to 2421 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
BJ994673 hepatoblastoma .a 1918 to 2366 449 to 1       449/449
(100 %)
0 diff
(100 %id)
DA435261 tongue, tumor tissue .a 1921 to 2496 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA764867 tongue .a 1959 to 2535 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DB265691 uterus .a 2006 to 2581 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
BP270196 small intestine .a 2138 to 2719 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA188874 amygdala .a 2171 to 2709 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
BU175716 large cell carcinoma, lung .a 2179 to 2947 1 to 776       776/868
(89 %)
14 diff
(98.4 %id)
CN258120 embryonic stem cells, cell lines H1, H7, andH9 .a 2181 to 2909 1 to 729       729/729
(100 %)
2 diff
(99.8 %id)
BY799757 eye .a 2347 to 2957 1 to 611       611/611
(100 %)
0 diff
(100 %id)
DC319698 brain .a 2456 to 3029 1 to 574       574/574
(100 %)
0 diff
(100 %id)
BE018154 cervical carcinoma cell line, cervix .a 2466 to 2974 1 to 509       509/509
(100 %)
0 diff
(100 %id)
DC349420   .a 2488 to 3042 1 to 555       555/555
(100 %)
0 diff
(100 %id)
CN258115 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2493 to 3125 1 to 633   tiling clone,   633/633
(100 %)
0 diff
(100 %id)
DC384063 Prostate .a 2597 to 3178 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BG186691   .a 2621 to 3346 1 to 726   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 726/727
(99 %)
10 diff
(98.7 %id)
BG212703   .a 2621 to 3346 1 to 727   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 727/730
(99 %)
9 diff
(98.8 %id)
BG214813   .a 2621 to 3348 1 to 728   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 728/728
(100 %)
5 diff
(99.4 %id)
DC349051   .a 2648 to 3218 1 to 571       571/571
(100 %)
0 diff
(100 %id)
BE878529 large cell carcinoma, undifferentiated, lung .a 2657 to 3265 1 to 609       609/609
(100 %)
1 diff
(99.9 %id)
BF968083 adrenal cortex carcinoma, cell line, adrenal gland .a 2673 to 3416 1 to 745       745/955
(78 %)
15 diff
(98.5 %id)
CV572776 cornea, eye .a 2691 to 3297 1 to 607       607/607
(100 %)
0 diff
(100 %id)
BJ989723 hepatoblastoma .a 2724 to 3310 1 to 587       587/587
(100 %)
0 diff
(100 %id)
FN098432 breast carcinoma .a 2731 to 2795 65 to 1     Submitted on the opposite strand 65/66
(98 %)
0 diff
(100 %id)
BM990769 lung, Lung Focal Fibrosis .a 2825 to 3472 666 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 648/648
(100 %)
2 diff
(99.7 %id)
DA892476 rectum .a 3019 to 3595 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
AI381305   .a 3056 to 3351 296 to 1       296/296
(100 %)
0 diff
(100 %id)
BQ430539 large cell carcinoma, lung .a 3076 to 3867 90 to 885   tiling clone,   796/850
(93 %)
6 diff
(99.3 %id)
BX477471   .a 3121 to 3619 1 to 499       499/499
(100 %)
0 diff
(100 %id)
BF197903 skin, normal, 4 pooled samples .a 3176 to 3348 173 to 1       173/173
(100 %)
0 diff
(100 %id)
FN118004 breast carcinoma .a 3197 to 3310 112 to 1     Submitted on the opposite strand 112/113
(99 %)
5 diff
(95.6 %id)
N40862 placenta .a 3219 to 3421 1 to 203       203/203
(100 %)
0 diff
(100 %id)
FN057720 breast carcinoma .a 3261 to 3347 92 to 3     Submitted on the opposite strand 90/92
(97 %)
0 diff
(100 %id)
BM763240 myeloma .a 3347 to 4065 1 to 719       719/719
(100 %)
0 diff
(100 %id)
BM763887 myeloma .a 3347 to 4040 1 to 694       694/694
(100 %)
0 diff
(100 %id)
CN258116 embryonic stem cells, cell lines H1, H7, andH9 .a 3348 to 4079 1 to 730       730/730
(100 %)
5 diff
(99.4 %id)
CN258119 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3369 to 4036 1 to 669       669/669
(100 %)
2 diff
(99.8 %id)
CN483010 eye .a 3376 to 3992 1 to 617       617/617
(100 %)
0 diff
(100 %id)
AA309069 colon .a 3422 to 3618 1 to 197       197/197
(100 %)
0 diff
(100 %id)
BE785563 large cell carcinoma, lung .a 3436 to 4124 1 to 689       689/900
(76 %)
14 diff
(98.5 %id)
BM046589 carcinoma, cell line, Prostate .a 3464 to 4263 1 to 809       809/809
(100 %)
12 diff
(98.6 %id)
BX642250   .a 3481 to 3986 1 to 506       506/506
(100 %)
0 diff
(100 %id)
BU172326 melanotic melanoma, skin .a 3498 to 4325 12 to 840       829/845
(98 %)
3 diff
(99.7 %id)
AF339775   .a 3559 to 5577 1 to 2019   tiling clone, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 2019/2019
(100 %)
0 diff
(100 %id)
BG562663 Liver .a 3572 to 4271 1 to 700       700/700
(100 %)
7 diff
(99.0 %id)
BG571328 placenta .a 3572 to 4375 1 to 801       801/842
(95 %)
27 diff
(96.8 %id)
AK096383   .a 3579 to 5577 1 to 1999   available from FLJ,   1999/1999
(100 %)
3 diff
(99.9 %id)
DA749118   .a 3580 to 4150 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
CB998544 Blood vessels - aorta, basilar and artery .a 3590 to 4381 1 to 795       795/795
(100 %)
8 diff
(99.0 %id)
AA291770 ovarian tumor, ovary .a 3595 to 4107 1 to 512       512/515
(99 %)
2 diff
(99.7 %id)
BF218467 brain, glioblastoma .a 3612 to 4323 1 to 703       703/848
(82 %)
21 diff
(97.6 %id)
CN258121 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3618 to 4231 1 to 614       614/614
(100 %)
0 diff
(100 %id)
BE550654 carcinoid, lung .a 3643 to 4006 364 to 1       364/364
(100 %)
0 diff
(100 %id)
BE671112 carcinoid, lung .a 3644 to 4014 371 to 1       371/371
(100 %)
0 diff
(100 %id)
CD105030 Pooled-Skin .a 3691 to 4332 1 to 645       645/693
(93 %)
8 diff
(98.9 %id)
AW848186 colon .a 3732 to 3836 1 to 105       105/105
(100 %)
0 diff
(100 %id)
BE877049 large cell carcinoma, undifferentiated, lung .a 3828 to 4400 1 to 572       572/572
(100 %)
1 diff
(99.9 %id)
BG285661 bladder, transitional cell papilloma, cell line .a 4012 to 4728 1 to 717       717/890
(80 %)
22 diff
(97.6 %id)
TI_149274617   .a 4040 to 4904 985 to 124   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 862/1004
(85 %)
18 diff
(98.3 %id)
TI_149303683   .a 4040 to 4897 937 to 97   AAA   841/950
(88 %)
0 diff
(100 %id)
CK823211 Islets of Langerhans, Pancreas .a 4042 to 4620 12 to 590       579/590
(98 %)
6 diff
(99.0 %id)
BM790110 stomach .a 4058 to 4736 1 to 678       678/678
(100 %)
1 diff
(99.9 %id)
CN258124 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 4072 to 4746 1 to 676       676/679
(99 %)
3 diff
(99.6 %id)
TI_154130438   .a 4090 to 4904 885 to 87   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 799/1000
(79 %)
22 diff
(97.8 %id)
BG249212 hypernephroma, cell line, Kidney .a 4105 to 4896 1 to 776       776/978
(79 %)
24 diff
(97.6 %id)
FN112191 breast carcinoma .a 4124 to 4210 1 to 87       87/87
(100 %)
0 diff
(100 %id)
TI_154126558   .a 4124 to 4904 856 to 79   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 778/962
(80 %)
3 diff
(99.7 %id)
CA416660 Chondrosarcoma Cell line .a 4124 to 4904 796 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 778/840
(92 %)
3 diff
(99.7 %id)
TI_154061392   .a 4129 to 4909 844 to 73   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 772/877
(88 %)
12 diff
(98.7 %id)
TI_149298521   .a 4135 to 4904 851 to 85   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 767/816
(93 %)
18 diff
(97.8 %id)
BQ018990 lung, Metastatic Chondrosarcoma .a 4169 to 4904 750 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 732/733
(99 %)
5 diff
(99.4 %id)
CA420566 Bone, Enchondroma cell line .a 4178 to 4909 746 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 728/732
(99 %)
4 diff
(99.5 %id)
BU621604 cell lines, Chondrosarcoma .a 4184 to 4904 735 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 717/717
(100 %)
4 diff
(99.5 %id)
BE878092 large cell carcinoma, undifferentiated, lung .a 4211 to 4837 1 to 628       628/877
(71 %)
4 diff
(99.6 %id)
CN258118 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 4270 to 4950 12 to 692       681/692
(98 %)
6 diff
(99.2 %id)
N30209 placenta .a 4290 to 4904 615 to 1       615/617
(99 %)
16 diff
(97.5 %id)
BU676256 lung, Primary Lung Epithelial Cells .a 4295 to 4904 628 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 610/610
(100 %)
1 diff
(99.9 %id)
BJ989724 hepatoblastoma .a 4349 to 4888 540 to 1       540/540
(100 %)
0 diff
(100 %id)
BF591041 colon, colon tumor, RER+ .a 4362 to 4904 543 to 1       543/543
(100 %)
0 diff
(100 %id)
AW269368 Kidney .a 4366 to 4904 539 to 1       539/539
(100 %)
0 diff
(100 %id)
BM851748 stomach .a 4386 to 4909 1 to 524   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 524/524
(100 %)
0 diff
(100 %id)
AW769236 colon, moderately-differentiated adenocarcinoma .a 4394 to 4909 516 to 1       516/516
(100 %)
0 diff
(100 %id)
BE301636 cervical carcinoma cell line, cervix .a 4398 to 4905 512 to 5       508/512
(99 %)
0 diff
(100 %id)
BM983246 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 4403 to 4904 520 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 502/502
(100 %)
0 diff
(100 %id)
AA291771 ovarian tumor, ovary .a 4405 to 4905 503 to 2       502/504
(99 %)
0 diff
(100 %id)
AI963192 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 4420 to 4904 485 to 1       485/485
(100 %)
0 diff
(100 %id)
AW771068 colon, juvenile granulosa tumor .a 4440 to 4904 465 to 1       465/465
(100 %)
0 diff
(100 %id)
AV703195 adrenal gland .a 4452 to 5158 1 to 707       707/709
(99 %)
11 diff
(98.5 %id)
AW131367 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 4456 to 4904 449 to 1       449/449
(100 %)
0 diff
(100 %id)
AA676497   .a 4480 to 4905 426 to 1       426/426
(100 %)
0 diff
(100 %id)
AI240944 Kidney .a 4485 to 4900 416 to 1       416/416
(100 %)
0 diff
(100 %id)
BE569134 bladder, carcinoma, cell line .a 4496 to 5108 1 to 615       615/710
(86 %)
19 diff
(97.4 %id)
AA595170 breast .a 4498 to 4903 406 to 1       406/406
(100 %)
0 diff
(100 %id)
BE326858 Kidney .a 4514 to 4904 411 to 21   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 391/391
(100 %)
0 diff
(100 %id)
AI031762 parathyroid gland, parathyroid tumor .a 4517 to 4909 403 to 11   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 393/393
(100 %)
0 diff
(100 %id)
FN171669 breast carcinoma .a 4518 to 4613 1 to 96       96/96
(100 %)
0 diff
(100 %id)
AA502286 colon .a 4537 to 4899 377 to 15   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 363/363
(100 %)
0 diff
(100 %id)
AA576983 colon, colon tumor RER+ .a 4553 to 4904 364 to 13   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 352/352
(100 %)
0 diff
(100 %id)
AI873725 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 4598 to 4904 307 to 1       307/307
(100 %)
0 diff
(100 %id)
AA548062 adrenal adenoma, adrenal gland .a 4599 to 4888 290 to 1       290/290
(100 %)
0 diff
(100 %id)
AI473329 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4655 to 4905 251 to 1       251/251
(100 %)
0 diff
(100 %id)
DB330523 rectum .a 4715 to 4904 191 to 1       191/191
(100 %)
2 diff
(99.0 %id)
AA704336 pineal gland .a 4718 to 5141 424 to 1       424/424
(100 %)
0 diff
(100 %id)
CD722024 eye, lacrimal gland .a 4797 to 5425 1 to 629       629/629
(100 %)
0 diff
(100 %id)
BM756128 Ascites, stomach .a 4866 to 5532 1 to 667       667/667
(100 %)
0 diff
(100 %id)
TI_154099697   .a 4899 to 5577 783 to 105   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 679/679
(100 %)
3 diff
(99.6 %id)
CA441155 Fibrosarcoma .a 4946 to 5577 650 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 632/632
(100 %)
1 diff
(99.9 %id)
CK823210 Islets of Langerhans, Pancreas .a 5001 to 5577 591 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 573/573
(100 %)
4 diff
(99.4 %id)
DB325042   .a 5023 to 5577 555 to 1       555/562
(98 %)
2 diff
(99.7 %id)
AI401528 anaplastic oligodendroglioma, brain .a 5090 to 5578 489 to 1   tiling clone,   489/489
(100 %)
0 diff
(100 %id)
AI911923 adenocarcinoma, Pancreas .a 5095 to 5576 482 to 1       482/482
(100 %)
0 diff
(100 %id)
AW021435 cochlea, ear .a 5118 to 5577 8 to 463   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 456/463
(98 %)
6 diff
(98.8 %id)
AW069198 bone marrow stroma .a 5119 to 5577 485 to 27   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 459/459
(100 %)
0 diff
(100 %id)
AW612493 Kidney .a 5120 to 5577 458 to 1       458/458
(100 %)
0 diff
(100 %id)
AI754139 bone marrow stroma .a 5150 to 5577 450 to 23   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 428/428
(100 %)
0 diff
(100 %id)
BI492390 cochlea, ear .a 5157 to 5577 438 to 22   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 417/417
(100 %)
2 diff
(99.6 %id)
AI753922 bone marrow stroma .a 5163 to 5576 434 to 21   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 414/414
(100 %)
0 diff
(100 %id)
NM_001164750.1   .b 1 to 5153 1 to 5153 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 5153/5153
(100 %)
0 diff
(100 %id)
DN993915 brain, whole brain .b 1 to 558 9 to 566   tiling clone,   558/566
(98 %)
6 diff
(99.0 %id)
DN993665 brain, whole brain .b 29 to 555 8 to 535       528/535
(98 %)
7 diff
(98.7 %id)
BG701542 brain, hippocampus .b 34 to 748 1 to 715       715/715
(100 %)
13 diff
(98.2 %id)
DB727902 hippocampus .b 39 to 706 1 to 668       668/668
(100 %)
1 diff
(99.9 %id)
N83868   .b 43 to 301 1 to 257       257/257
(100 %)
15 diff
(94.2 %id)
AK304314 trachea .b 45 to 2594 1 to 2550 D490N D570Y F705L tiling clone,   2550/2550
(100 %)
5 diff
(99.9 %id)
DC417874 trachea .b 45 to 594 1 to 550       550/550
(100 %)
0 diff
(100 %id)
BI757421 brain .b 53 to 666 1 to 617       617/617
(100 %)
23 diff
(96.3 %id)
TI_57220377   .b 53 to 666 31 to 647       617/647
(95 %)
22 diff
(96.6 %id)
BI546417 brain, hippocampus .b 54 to 693 1 to 641       641/644
(99 %)
18 diff
(97.3 %id)
DB468633 hippocampus .b 59 to 675 1 to 618       618/727
(85 %)
11 diff
(98.5 %id)
DB482964 hippocampus .b 59 to 564 1 to 506       506/508
(99 %)
2 diff
(99.7 %id)
TI_44166420   .b 59 to 693 97 to 732       636/735
(86 %)
16 diff
(97.9 %id)
DC373512 tongue .b 88 to 662 1 to 577       577/582
(99 %)
3 diff
(99.5 %id)
AI267311 brain, frontal lobe (see description) .b 96 to 552 473 to 18       456/574
(79 %)
3 diff
(99.5 %id)
DA173583 amygdala .b 148 to 466 2 to 320   capped   319/319
(100 %)
1 diff
(99.7 %id)
FJ461473   .c 1 to 1287 1 to 1287 L379P tiling clone,   1287/1287
(100 %)
3 diff
(99.8 %id)
DB468723 hippocampus .d 1 to 715 2 to 716   tiling clone,   716/727
(98 %)
7 diff
(99.1 %id)
DB478083 hippocampus .d 1 to 709 2 to 710   tiling clone,   710/710
(100 %)
4 diff
(99.5 %id)
CN483754 eye .d 668 to 1292 5 to 629   tiling clone,   629/629
(100 %)
1 diff
(99.9 %id)
NM_032466.3   .e 1 to 3774 1 to 3774 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 3774/3774
(100 %)
0 diff
(100 %id)
AK291836   .e 188 to 1719 1 to 1533 A103G tiling clone,   1533/1533
(100 %)
6 diff
(99.7 %id)
AF289489 Liver .e 259 to 2939 1 to 2680 exact tiling clone,   2680/2680
(100 %)
6 diff
(99.8 %id)
BX459083 placenta .e 371 to 1413 1 to 1030       1030/1085
(94 %)
14 diff
(98.8 %id)
BQ232651 large cell carcinoma, lung .e 708 to 1565 5 to 866       862/868
(99 %)
16 diff
(98.2 %id)
BG166775 hypernephroma, cell line, Kidney .e 710 to 1388 1 to 682       679/769
(88 %)
16 diff
(98.0 %id)
TI_1959498556   .e 760 to 1324 603 to 1163     Submitted on the opposite strand 561/657
(85 %)
15 diff
(97.8 %id)
DA596698   .e 787 to 1346 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
CV571584 cornea, eye .e 861 to 1448 1 to 588       588/588
(100 %)
0 diff
(100 %id)
BX434349 placenta .e 2168 to 2943 785 to 1   tiling clone,   785/845
(92 %)
37 diff
(95.7 %id)
DB464677 hippocampus .f 1 to 672 1 to 678       678/678
(100 %)
24 diff
(96.5 %id)
DB727842 hippocampus .f 2 to 686 1 to 685   tiling clone,   685/685
(100 %)
4 diff
(99.5 %id)
DA750518   .f 17 to 584 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
DA301843 hippocampus .f 19 to 596 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
DA657661   .f 19 to 592 2 to 575   capped   574/574
(100 %)
3 diff
(99.5 %id)
DA362018 subthalamic nucleus .f 21 to 582 2 to 563   capped   562/562
(100 %)
3 diff
(99.5 %id)
DA783762 brain .f 21 to 598 2 to 579   capped   578/578
(100 %)
3 diff
(99.5 %id)
DA231178 brain .f 27 to 562 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
DA167777 amygdala .f 33 to 573 2 to 542   capped   541/541
(100 %)
3 diff
(99.5 %id)
DA289123 hippocampus .f 49 to 615 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DA104823 cerebellum .f 51 to 573 2 to 524   capped   523/528
(99 %)
2 diff
(99.7 %id)
DA658135   .f 54 to 623 2 to 571   capped   570/570
(100 %)
3 diff
(99.5 %id)
DA393443 thalamus .f 66 to 653 2 to 589   capped   588/588
(100 %)
2 diff
(99.7 %id)
DA122281 cerebellum .f 67 to 622 2 to 557   capped   556/557
(99 %)
1 diff
(99.9 %id)
DA169361 amygdala .f 67 to 645 2 to 580   capped   579/579
(100 %)
3 diff
(99.5 %id)
DA153743 amygdala .f 71 to 637 2 to 571   capped   570/570
(100 %)
6 diff
(99.0 %id)
DB471681 hippocampus .f 76 to 570 1 to 495       495/495
(100 %)
3 diff
(99.4 %id)
DB495446 hypothalamus .f 76 to 578 1 to 503       503/503
(100 %)
2 diff
(99.7 %id)
DB497100 hypothalamus .f 76 to 566 1 to 491       491/491
(100 %)
2 diff
(99.6 %id)
DA109623 cerebellum .f 77 to 647 2 to 572   tiling clone, capped   571/571
(100 %)
0 diff
(100 %id)
DB466729 hippocampus .f 88 to 526 1 to 440       440/440
(100 %)
20 diff
(95.5 %id)
F07451 brain, total brain .f 253 to 582 1 to 330       330/330
(100 %)
3 diff
(99.1 %id)
DC357449   .f 570 to 1142 1 to 573   tiling clone,   573/573
(100 %)
1 diff
(99.9 %id)
NM_032468.4   .g 1 to 3624 1 to 3624 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 3624/3624
(100 %)
0 diff
(100 %id)
TI_1959503291   .g 71 to 1177 61 to 1160 P268L P296L P297L tiling clone, Submitted on the opposite strand 1100/1261
(87 %)
29 diff
(97.8 %id)
NM_001164751.1   .h 1 to 3621 1 to 3621 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 3621/3621
(100 %)
0 diff
(100 %id)
TI_2194644741   .h 71 to 1195 48 to 1161 E257D E293K V294Y P295H P296Q ...     1114/1255
(88 %)
29 diff
(97.7 %id)
TI_2194645553   .h 71 to 1176 49 to 1134 E290T Q291A Q292E E293V V294P ...     1086/1238
(87 %)
25 diff
(98.0 %id)
BC144362 Brain, cerebellum, PCR rescued clones .h 71 to 2728 1 to 2657 exact tiling clone,   2657/2657
(100 %)
2 diff
(100.0 %id)
DA130353 alzheimer cortex .h 658 to 1216 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
CN368825 embryonic stem cells, cell lines H1, H7, andH9 .h 722 to 1326 1 to 606       606/606
(100 %)
2 diff
(99.7 %id)
BF969448 adrenal cortex carcinoma, cell line, adrenal gland .h 770 to 1477 1 to 701       701/909
(77 %)
13 diff
(98.6 %id)
NM_001164754.1   .i 1 to 3717 1 to 3717 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 3717/3717
(100 %)
0 diff
(100 %id)
AU132666   .i 80 to 844 2 to 766   tiling clone, capped   765/765
(100 %)
0 diff
(100 %id)
BC015518 Lung, carcinoma, large cellundifferentiated. .i 82 to 1146 1 to 1065   tiling clone, available from MGC, AAA   1065/1065
(100 %)
2 diff
(99.9 %id)
BU166117 melanotic melanoma, skin .i 142 to 1000 1 to 862       862/918
(93 %)
5 diff
(99.5 %id)
AW994191 breast_normal .i 725 to 1382 662 to 5   tiling clone, Submitted on the opposite strand 658/662
(99 %)
2 diff
(99.7 %id)
BF696971 brain, primitive neuroectoderm .i 879 to 1561 1 to 684   tiling clone,   684/922
(74 %)
19 diff
(98.0 %id)
DB369682   .i 2336 to 2871 536 to 1   tiling clone,   536/536
(100 %)
0 diff
(100 %id)
NM_001164752.1   .j 1 to 3564 1 to 3564 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 3564/3564
(100 %)
0 diff
(100 %id)
DB470384 hippocampus .j 39 to 718 1 to 680   tiling clone,   680/680
(100 %)
3 diff
(99.6 %id)
TI_1959501473   .j 71 to 771 705 to 6       700/1267
(55 %)
0 diff
(100 %id)
TI_2194644754   .j 71 to 1266 66 to 1236 E274K V275Y P276H P277Q D278I ...   Submitted on the opposite strand 1138/1238
(91 %)
42 diff
(96.7 %id)
TI_2194645938   .j 71 to 1222 63 to 1205 exact   Submitted on the opposite strand 1143/1261
(90 %)
43 diff
(96.6 %id)
BC144363 Brain, cerebellum, PCR rescued clones .j 71 to 2671 1 to 2601 exact tiling clone,   2601/2601
(100 %)
3 diff
(99.9 %id)
NM_001164755.1   .k 1 to 3645 1 to 3645 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 3645/3645
(100 %)
0 diff
(100 %id)
BC025236 Pancreas, epithelioid carcinoma .k 73 to 2816 1 to 2743 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 2743/2743
(100 %)
2 diff
(100.0 %id)
BQ889709 dorsal root ganglia .k 102 to 888 1 to 793       791/857
(92 %)
16 diff
(98.2 %id)
BU190749 ductal carcinoma, cell line, Pancreas .k 157 to 1168 1 to 1013 Q215P I231*     1013/1014
(99 %)
32 diff
(96.9 %id)
TI_1948218067   .k 266 to 1084 135 to 959   fully sequenced,   823/957
(85 %)
26 diff
(97.3 %id)
TI_1948218235   .k 266 to 439 135 to 308   fully sequenced,   174/198
(87 %)
6 diff
(97.0 %id)
TI_1948218572   .k 266 to 1078 134 to 948   fully sequenced,   815/948
(85 %)
17 diff
(98.3 %id)
EL735337 mixed .k 270 to 932 1 to 663       663/663
(100 %)
0 diff
(100 %id)
TI_1948218236   .k 409 to 1081 794 to 123   fully sequenced,   672/794
(84 %)
2 diff
(99.8 %id)
BG170148 hypernephroma, cell line, Kidney .k 471 to 1157 1 to 682       682/682
(100 %)
7 diff
(99.0 %id)
DC321194 brain .k 536 to 1063 1 to 528       528/528
(100 %)
0 diff
(100 %id)
DC355371   .k 552 to 1131 1 to 580       580/580
(100 %)
0 diff
(100 %id)
TI_1948218068   .k 561 to 1081 645 to 124   fully sequenced,   522/645
(80 %)
1 diff
(99.9 %id)
DC424900   .k 563 to 1118 1 to 556       556/556
(100 %)
0 diff
(100 %id)
AL694159   .k 760 to 1281 6 to 527       527/527
(100 %)
0 diff
(100 %id)
TI_1948218573   .k 762 to 1081 442 to 123   fully sequenced,   320/442
(72 %)
0 diff
(100 %id)
CD512083 Pooled-Skin .k 780 to 1602 1 to 830       830/862
(96 %)
14 diff
(98.4 %id)
TI_1959501463   .k 784 to 1863 1084 to 5       1080/1276
(84 %)
5 diff
(99.7 %id)
CF619299 Pooled Chondrosarcoma Tumor cells .k 796 to 1528 27 to 774       748/927
(80 %)
36 diff
(96.2 %id)
BE178059 head_neck .k 807 to 1444 636 to 1     Submitted on the opposite strand 636/636
(100 %)
2 diff
(99.7 %id)
DB180778 kidney, tumor tissue .k 809 to 1369 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
BM785946 Ascites, stomach .k 832 to 1446 1 to 614       614/614
(100 %)
2 diff
(99.7 %id)
DA141215 alzheimer cortex .k 906 to 1445 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
CA396540 eye, RPE/choroid .k 947 to 1484 1 to 538       538/538
(100 %)
0 diff
(100 %id)
AA593699 breast, breast tumor .k 960 to 1239 290 to 11   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 280/280
(100 %)
0 diff
(100 %id)
BG286297 bladder, transitional cell papilloma, cell line .k 1010 to 1643 1 to 630       630/1022
(61 %)
6 diff
(99.5 %id)
DA829491 placenta .k 1034 to 1863 2 to 843   capped   842/850
(99 %)
14 diff
(98.4 %id)
BG577429   .k 1067 to 1501 435 to 1     Submitted on the opposite strand 435/435
(100 %)
0 diff
(100 %id)
DB245609 uterus, tumor tissue .k 1078 to 1629 2 to 554   capped   553/553
(100 %)
2 diff
(99.7 %id)
BM450723 eye, retinoblastoma .k 1081 to 1967 1 to 909       909/1041
(87 %)
36 diff
(96.6 %id)
AA309066 colon .k 1094 to 1253 1 to 160       160/160
(100 %)
0 diff
(100 %id)
BI793083 Islets of Langerhans, Pancreas .k 1105 to 1679 1 to 575       575/575
(100 %)
0 diff
(100 %id)
BI793252 Islets of Langerhans, Pancreas .k 1105 to 1522 1 to 418       418/425
(98 %)
1 diff
(99.8 %id)
BG260159 bladder, transitional cell papilloma, cell line .k 1152 to 1773 1 to 622       622/622
(100 %)
1 diff
(99.9 %id)
BG674248 skin .k 1276 to 2189 1 to 906       906/909
(99 %)
29 diff
(96.9 %id)
T07611   .k 1284 to 1632 1 to 350       350/350
(100 %)
1 diff
(99.8 %id)
BE787280 large cell carcinoma, lung .k 1328 to 2125 1 to 795       795/873
(91 %)
34 diff
(96.2 %id)
BE787443 large cell carcinoma, lung .k 1328 to 1984 1 to 654       654/954
(68 %)
4 diff
(99.6 %id)
N26443 melanocyte .k 1357 to 1702 1 to 347       347/347
(100 %)
1 diff
(99.8 %id)
BG291228 bladder, transitional cell papilloma, cell line .k 1362 to 2126 1 to 758       758/827
(91 %)
14 diff
(98.4 %id)
CN368822 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k 1388 to 2106 1 to 718   tiling clone,   718/718
(100 %)
1 diff
(99.9 %id)
CB145142 Liver .k 1460 to 1933 1 to 474       474/474
(100 %)
2 diff
(99.6 %id)
AA424475   .k 1485 to 1921 1 to 436       436/436
(100 %)
1 diff
(99.8 %id)
EL949954 eyeball .k 1488 to 2080 1 to 593       593/593
(100 %)
7 diff
(98.9 %id)
BG499945 adenocarcinoma, Prostate .k 1497 to 2156 1 to 659       659/660
(99 %)
5 diff
(99.3 %id)
TI_1959498543   .k 1512 to 2762 1282 to 49     Submitted on the opposite strand 1234/1288
(95 %)
0 diff
(100 %id)
CR735834 senescent fibroblast .k 1539 to 2147 1 to 608       608/608
(100 %)
2 diff
(99.7 %id)
BE880647 large cell carcinoma, undifferentiated, lung .k 1555 to 2346 1 to 774       774/909
(85 %)
29 diff
(96.9 %id)
BG611332 adenocarcinoma, Prostate .k 1572 to 2391 1 to 809       809/815
(99 %)
22 diff
(97.4 %id)
TI_2194644743   .k 1589 to 2752 1204 to 58     Submitted on the opposite strand 1147/1300
(88 %)
0 diff
(100 %id)
BE748027 bone marrow, from acute myelogenous leukemia .k 1589 to 2249 1 to 653       653/853
(76 %)
13 diff
(98.5 %id)
CB115846 Liver .k 1595 to 2076 1 to 482       482/482
(100 %)
0 diff
(100 %id)
CD252384 White Matter .k 1597 to 2360 24 to 803       780/981
(79 %)
30 diff
(97.0 %id)
BM798029 Ascites, stomach .k 1599 to 2035 1 to 436       436/436
(100 %)
1 diff
(99.8 %id)
BF970721 adrenal cortex carcinoma, cell line, adrenal gland .k 1610 to 2365 1 to 748       748/748
(100 %)
12 diff
(98.4 %id)
CB986538 Pooled-Glandular .k 1624 to 2325 1 to 712       712/753
(94 %)
21 diff
(97.3 %id)
BF213359 bone marrow, from acute myelogenous leukemia .k 1636 to 2275 1 to 633       633/774
(81 %)
15 diff
(98.1 %id)
BG499402 adenocarcinoma, Prostate .k 1640 to 2334 1 to 695       695/839
(82 %)
10 diff
(98.9 %id)
BG528772 adenocarcinoma, Prostate .k 1654 to 2319 1 to 666       666/666
(100 %)
2 diff
(99.7 %id)
BF207523 bladder, carcinoma, cell line .k 1657 to 2320 1 to 647       647/736
(87 %)
25 diff
(96.7 %id)
BF692713 melanotic melanoma, high MDR, skin .k 1659 to 2288 1 to 625       625/854
(73 %)
10 diff
(98.9 %id)
BM799049 Ascites, stomach .k 1663 to 2079 1 to 416       416/416
(100 %)
4 diff
(99.1 %id)
TI_2194644752   .k 1664 to 2761 1147 to 62       1086/1273
(85 %)
0 diff
(100 %id)
CD512637 Pooled-Skin .k 1692 to 2360 1 to 670       670/763
(87 %)
9 diff
(98.9 %id)
TI_1959502909   .k 1705 to 2762 1093 to 48     Submitted on the opposite strand 1046/1288
(81 %)
0 diff
(100 %id)
TI_2194645934   .k 1705 to 2761 1114 to 60       1055/1282
(82 %)
0 diff
(100 %id)
TI_2194645557   .k 1713 to 2752 1092 to 56     Submitted on the opposite strand 1037/1294
(80 %)
0 diff
(100 %id)
BF790217 muscle (skeletal) .k 1727 to 2465 1 to 732       732/732
(100 %)
17 diff
(97.7 %id)
BM795015 Ascites, stomach .k 1748 to 2181 1 to 434       434/434
(100 %)
0 diff
(100 %id)
BE619014 large cell carcinoma, lung .k 1750 to 2519 1 to 757       757/898
(84 %)
26 diff
(97.2 %id)
AA304742 Bone .k 1810 to 2097 1 to 289       289/289
(100 %)
1 diff
(99.7 %id)
CB107396 Liver .k 1820 to 2214 1 to 395       395/395
(100 %)
0 diff
(100 %id)
DA727921   .k 1821 to 2390 2 to 571   capped   570/570
(100 %)
4 diff
(99.3 %id)
AI902785 breast .k 1825 to 2079 255 to 1       255/255
(100 %)
1 diff
(99.7 %id)
CB122028 Liver .k 1825 to 2285 1 to 461       461/461
(100 %)
0 diff
(100 %id)
AI902787 breast .k 1826 to 2078 253 to 1       253/254
(99 %)
0 diff
(100 %id)
BG165240 hypernephroma, cell line, Kidney .k 1858 to 2595 1 to 733       733/955
(76 %)
19 diff
(98.1 %id)
BG164978 hypernephroma, cell line, Kidney .k 1858 to 2630 1 to 777       777/872
(89 %)
20 diff
(97.8 %id)
BE739557 hypernephroma, Kidney .k 1872 to 2766 899 to 4       896/904
(99 %)
0 diff
(100 %id)
TI_154059066   .k 1877 to 2818 998 to 81   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 918/1005
(91 %)
24 diff
(97.7 %id)
CR614279 Placenta Cot 25-normalized .k 1889 to 2818 1 to 930   tiling clone,   930/930
(100 %)
0 diff
(100 %id)
AL547861 placenta, Placenta Cot 25-normalized .k 1889 to 2818 1 to 930   fully sequenced,   930/930
(100 %)
2 diff
(99.8 %id)
BG249195 hypernephroma, cell line, Kidney .k 1902 to 2678 1 to 768       768/939
(81 %)
24 diff
(97.5 %id)
BG249108 hypernephroma, cell line, Kidney .k 1903 to 2616 1 to 710       710/982
(72 %)
9 diff
(99.1 %id)
BU175347 large cell carcinoma, lung .k 1920 to 2647 1 to 739       739/931
(79 %)
33 diff
(96.5 %id)
BM907408 large cell carcinoma, lung .k 1933 to 2818 12 to 905       894/975
(91 %)
18 diff
(98.2 %id)
TI_154060878   .k 1957 to 2819 956 to 110   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 847/969
(87 %)
38 diff
(96.1 %id)
AA037341 senescent fibroblast .k 1958 to 2379 1 to 424       424/424
(100 %)
3 diff
(99.3 %id)
TI_149307255   .k 1980 to 2818 925 to 99   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 827/924
(89 %)
21 diff
(97.8 %id)
CD677019 eye, Trabecular meshwork .k 1984 to 2621 1 to 638       638/638
(100 %)
2 diff
(99.7 %id)
BF699711 brain, primitive neuroectoderm .k 2000 to 2616 1 to 619       619/852
(72 %)
10 diff
(98.9 %id)
TI_154131603   .k 2024 to 2799 877 to 112   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 766/967
(79 %)
10 diff
(99.0 %id)
BE619679 large cell carcinoma, lung .k 2030 to 2745 742 to 24       719/742
(96 %)
0 diff
(100 %id)
BE546578 cervical carcinoma cell line, cervix .k 2031 to 2739 1 to 718       718/795
(90 %)
36 diff
(95.5 %id)
BU860966 mixed (pool of 40 RNAs) .k 2033 to 2739 1 to 724   AAA   724/832
(87 %)
39 diff
(95.4 %id)
BU621975 Cell Line, Chondrosarcoma .k 2047 to 2819 789 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 771/771
(100 %)
4 diff
(99.5 %id)
BQ775029 Bone, Human Chondrosarcoma Cell Line .k 2048 to 2799 763 to 16   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 748/748
(100 %)
5 diff
(99.4 %id)
BQ000046 Fibrosarcoma .k 2076 to 2830 767 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 749/749
(100 %)
6 diff
(99.2 %id)
DB533405 hippocampus .k 2077 to 2806 1 to 726     Submitted on the opposite strand 726/726
(100 %)
12 diff
(98.4 %id)
CA407340 adipose .k 2078 to 2809 731 to 1     Submitted on the opposite strand 731/731
(100 %)
9 diff
(98.8 %id)
CA419475 Bone, Human Chondrosarcoma Cell Line .k 2095 to 2818 740 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 722/727
(99 %)
3 diff
(99.6 %id)
TI_154099644   .k 2096 to 2799 794 to 91   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 704/705
(99 %)
9 diff
(98.8 %id)
CB268065 adipose .k 2099 to 2803 705 to 5     Submitted on the opposite strand 701/710
(98 %)
0 diff
(100 %id)
DB536136 hippocampus .k 2104 to 2816 1 to 711     Submitted on the opposite strand 711/713
(99 %)
5 diff
(99.3 %id)
CA420254 Bone, Enchondroma cell line .k 2105 to 2819 731 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 713/713
(100 %)
4 diff
(99.5 %id)
DB546729 hippocampus .k 2119 to 2816 1 to 693     Submitted on the opposite strand 693/695
(99 %)
7 diff
(99.0 %id)
DB532931 hippocampus .k 2125 to 2806 1 to 677     Submitted on the opposite strand 677/677
(100 %)
10 diff
(98.6 %id)
BU631680 cell lines, Chondrosarcoma .k 2125 to 2815 708 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 690/690
(100 %)
2 diff
(99.8 %id)
BF130361 hypernephroma, Kidney .k 2126 to 2762 1 to 629       629/791
(79 %)
13 diff
(98.4 %id)
CB069549 Pancreas, Purified pancreatic islet .k 2132 to 2684 1 to 553       553/558
(99 %)
2 diff
(99.7 %id)
BE748705 bone marrow, from acute myelogenous leukemia .k 2136 to 2755 632 to 11       622/632
(98 %)
0 diff
(100 %id)
CB268763 adipose .k 2137 to 2837 696 to 1   tiling clone, Submitted on the opposite strand 696/696
(100 %)
10 diff
(98.6 %id)
DB538504 hippocampus .k 2138 to 2811 1 to 670     Submitted on the opposite strand 670/670
(100 %)
7 diff
(99.0 %id)
TI_149278071   .k 2138 to 2818 767 to 86   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 682/684
(99 %)
7 diff
(99.0 %id)
BQ775449 Bone, Human Chondrosarcoma Cell Line .k 2141 to 2819 695 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 677/681
(99 %)
4 diff
(99.5 %id)
CA422202 Bone, Enchondroma cell line .k 2144 to 2818 693 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 675/675
(100 %)
0 diff
(100 %id)
CA423061 cell lines, Chondrosarcoma .k 2144 to 2811 686 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 668/668
(100 %)
1 diff
(99.9 %id)
DB539169 hippocampus .k 2146 to 2806 1 to 658     Submitted on the opposite strand 658/658
(100 %)
4 diff
(99.4 %id)
CA418101 Bone, Human Chondrosarcoma Cell Line .k 2146 to 2799 668 to 16   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 653/653
(100 %)
3 diff
(99.6 %id)
BG260297 bladder, transitional cell papilloma, cell line .k 2150 to 2819 1 to 669   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 669/669
(100 %)
2 diff
(99.8 %id)
BQ776186 Bone, Human Chondrosarcoma Cell Line .k 2150 to 2818 687 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 669/669
(100 %)
12 diff
(98.3 %id)
AV701892 adrenal gland .k 2151 to 2813 1 to 655       655/659
(99 %)
16 diff
(97.6 %id)
BU630646 cell lines, Chondrosarcoma .k 2160 to 2806 662 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 644/644
(100 %)
2 diff
(99.7 %id)
CA414926 Chondrosarcoma Grade II, Left Pelvis .k 2170 to 2816 665 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 647/647
(100 %)
0 diff
(100 %id)
CB268067 adipose .k 2179 to 2805 630 to 5     Submitted on the opposite strand 626/630
(99 %)
0 diff
(100 %id)
BQ020825 lung, Metastatic Chondrosarcoma .k 2180 to 2818 656 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 638/641
(99 %)
3 diff
(99.6 %id)
BU678196 lung .k 2181 to 2818 657 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 639/639
(100 %)
3 diff
(99.6 %id)
CA441120 Fibrosarcoma .k 2182 to 2799 633 to 16   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 618/618
(100 %)
2 diff
(99.7 %id)
BU686754 lung, Primary Lung Epithelial Cells .k 2186 to 2818 650 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 632/632
(100 %)
1 diff
(99.9 %id)
BM354082 Islets of Langerhans, Pancreas .k 2195 to 2722 1 to 528       528/528
(100 %)
0 diff
(100 %id)
BI792829 Islets of Langerhans, Pancreas .k 2222 to 2805 585 to 2       584/585
(99 %)
0 diff
(100 %id)
CA405866 adipose .k 2223 to 2815 590 to 1     Submitted on the opposite strand 590/590
(100 %)
5 diff
(99.2 %id)
AI084624 senescent fibroblast .k 2231 to 2818 600 to 13   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 588/588
(100 %)
1 diff
(99.9 %id)
BQ181232 Knee, Osteoarthritic Cartilage .k 2235 to 2819 603 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 585/585
(100 %)
0 diff
(100 %id)
AI674690 pooled .k 2243 to 2810 570 to 3       568/570
(99 %)
0 diff
(100 %id)
AI979241 pooled germ cell tumors .k 2243 to 2818 576 to 1       576/576
(100 %)
2 diff
(99.7 %id)
BF109935 pooled .k 2250 to 2808 559 to 1       559/559
(100 %)
2 diff
(99.7 %id)
CB146282 Liver .k 2267 to 2819 595 to 43   AAA Submitted on the opposite strand 553/553
(100 %)
5 diff
(99.1 %id)
DB374342 placenta .k 2270 to 2806 535 to 1       535/540
(99 %)
12 diff
(97.8 %id)
AA745282 Ewing's sarcoma .k 2288 to 2552 1 to 265       265/265
(100 %)
1 diff
(99.7 %id)
BM756639 Ascites, stomach .k 2292 to 2734 1 to 444       444/444
(100 %)
4 diff
(99.1 %id)
BM756218 Ascites, stomach .k 2292 to 2818 1 to 528       528/533
(99 %)
3 diff
(99.5 %id)
BM748487 Ascites, stomach .k 2292 to 2818 1 to 528   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 528/528
(100 %)
2 diff
(99.7 %id)
BM748495 Ascites, stomach .k 2292 to 2818 1 to 528   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 528/528
(100 %)
3 diff
(99.5 %id)
BM748499 Ascites, stomach .k 2292 to 2818 1 to 528   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 528/528
(100 %)
2 diff
(99.7 %id)
BM748439 Ascites, stomach .k 2292 to 2736 1 to 446       446/446
(100 %)
2 diff
(99.6 %id)
BM749250 Ascites, stomach .k 2292 to 2719 1 to 428       428/428
(100 %)
4 diff
(99.1 %id)
BM749721 Ascites, stomach .k 2292 to 2812 1 to 522       522/522
(100 %)
2 diff
(99.7 %id)
BM748246 Ascites, stomach .k 2292 to 2817 1 to 527       527/527
(100 %)
2 diff
(99.7 %id)
BM748302 Ascites, stomach .k 2292 to 2733 1 to 443       443/443
(100 %)
2 diff
(99.6 %id)
BM747238 Ascites, stomach .k 2292 to 2748 1 to 458       458/458
(100 %)
2 diff
(99.6 %id)
BM748424 Ascites, stomach .k 2292 to 2818 1 to 527   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 527/527
(100 %)
4 diff
(99.3 %id)
BM758246 Ascites, stomach .k 2292 to 2662 1 to 372       372/372
(100 %)
3 diff
(99.2 %id)
BM758890 Ascites, stomach .k 2292 to 2817 1 to 527       527/527
(100 %)
2 diff
(99.7 %id)
BM758018 Ascites, stomach .k 2292 to 2780 1 to 490       490/490
(100 %)
2 diff
(99.6 %id)
BF591055 colon, colon tumor, RER+ .k 2293 to 2818 526 to 1       526/526
(100 %)
0 diff
(100 %id)
AW439437 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .k 2294 to 2815 527 to 6       522/527
(99 %)
0 diff
(100 %id)
BF435767 pooled .k 2295 to 2818 536 to 13   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 524/524
(100 %)
1 diff
(99.9 %id)
BM749835 Ascites, stomach .k 2302 to 2796 1 to 496       496/496
(100 %)
4 diff
(99.2 %id)
BI793118 Islets of Langerhans, Pancreas .k 2328 to 2804 1 to 477       477/477
(100 %)
0 diff
(100 %id)
CB117195 Liver .k 2334 to 2818 1 to 485       485/486
(99 %)
1 diff
(99.8 %id)
AI650765 Kidney .k 2337 to 2818 482 to 1       482/482
(100 %)
4 diff
(99.2 %id)
AA788915 schizophrenic brain S-11 frontal lobe .k 2345 to 2796 452 to 1       452/452
(100 %)
1 diff
(99.8 %id)
AA827544 colon, colon tumor .k 2345 to 2818 474 to 1       474/474
(100 %)
1 diff
(99.8 %id)
AA602346 adrenal adenoma, adrenal gland .k 2346 to 2816 471 to 1       471/471
(100 %)
0 diff
(100 %id)
DB529016 hippocampus .k 2352 to 2816 1 to 465     Submitted on the opposite strand 465/467
(99 %)
2 diff
(99.6 %id)
AA767510 germinal center B cell .k 2353 to 2818 482 to 17   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 466/466
(100 %)
4 diff
(99.2 %id)
AI498630 Kidney .k 2356 to 2819 480 to 17   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 464/464
(100 %)
0 diff
(100 %id)
AI629034 Kidney .k 2356 to 2818 463 to 1       463/463
(100 %)
1 diff
(99.8 %id)
AI912527 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .k 2359 to 2818 461 to 2       460/461
(99 %)
0 diff
(100 %id)
C00261   .k 2370 to 2684 1 to 315       315/315
(100 %)
1 diff
(99.7 %id)
CV570058 cornea, eye .k 2392 to 2818 1 to 427   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 427/427
(100 %)
0 diff
(100 %id)
BG167928 hypernephroma, cell line, Kidney .k 2401 to 2818 1 to 414   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 414/414
(100 %)
4 diff
(99.1 %id)
AA576235 breast, breast tumor .k 2402 to 2818 417 to 1       417/417
(100 %)
0 diff
(100 %id)
BI792962 Islets of Langerhans, Pancreas .k 2403 to 2805 404 to 2       403/404
(99 %)
0 diff
(100 %id)
AA702708 liver and spleen .k 2409 to 2813 405 to 1       405/405
(100 %)
0 diff
(100 %id)
BF149386 skin .k 2410 to 2722 1 to 313       313/313
(100 %)
0 diff
(100 %id)
BE544061 cervical carcinoma cell line, cervix .k 2412 to 2819 1 to 408   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 408/408
(100 %)
0 diff
(100 %id)
AI921184 adenocarcinoma, Pancreas .k 2413 to 2817 405 to 1       405/405
(100 %)
1 diff
(99.8 %id)
AI290103 serous papillary carcinoma, high grade, 2pooled tumors, uterus .k 2428 to 2830 403 to 1       403/404
(99 %)
0 diff
(100 %id)
AI631254 Kidney, renal cell tumor .k 2429 to 2815 387 to 1       387/387
(100 %)
0 diff
(100 %id)
BE349065 malignant melanoma, metastatic to lymphnode, skin .k 2429 to 2818 404 to 15   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 390/390
(100 %)
0 diff
(100 %id)
N23024 melanocyte .k 2430 to 2818 391 to 1       391/391
(100 %)
3 diff
(99.3 %id)
BF590643 colon, colon tumor, RER+ .k 2434 to 2817 384 to 1       384/384
(100 %)
0 diff
(100 %id)
AW440370 serous papillary carcinoma, high grade, 2pooled tumors, uterus .k 2438 to 2816 382 to 4       379/382
(99 %)
0 diff
(100 %id)
BE789459 large cell carcinoma, lung .k 2443 to 2815 1 to 373   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 373/373
(100 %)
2 diff
(99.5 %id)
AA601990 adrenal adenoma, adrenal gland .k 2457 to 2780 324 to 1       324/324
(100 %)
1 diff
(99.7 %id)
BM754222 Ascites, stomach .k 2459 to 2811 1 to 353       353/353
(100 %)
0 diff
(100 %id)
AL547836 placenta, Placenta Cot 25-normalized .k 2479 to 2765 287 to 1   fully sequenced,   287/287
(100 %)
0 diff
(100 %id)
CA436424 Bone, Subchondral Bone .k 2492 to 2818 345 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 327/327
(100 %)
2 diff
(99.4 %id)
FN127011 breast carcinoma .k 2494 to 2604 112 to 1     Submitted on the opposite strand 112/112
(100 %)
1 diff
(99.2 %id)
AA301968 aorta .k 2499 to 2650 1 to 152       152/152
(100 %)
1 diff
(99.4 %id)
H90076 melanocyte .k 2514 to 2798 285 to 1       285/285
(100 %)
1 diff
(99.7 %id)
AI343345 colon, colon tumor, RER+ .k 2519 to 2818 300 to 1       300/300
(100 %)
1 diff
(99.7 %id)
N50951 multiple sclerosis lesions .k 2567 to 2804 238 to 1       238/238
(100 %)
1 diff
(99.6 %id)
AI636729 Kidney, renal cell tumor .k 2568 to 2818 262 to 12   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 251/251
(100 %)
0 diff
(100 %id)
BU623111 cell lines, Chondrosarcoma .k 2855 to 3645 809 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 791/791
(100 %)
2 diff
(99.8 %id)
TI_154031079   .k 3035 to 3639 675 to 71   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 605/953
(63 %)
0 diff
(100 %id)
CA442770 Fibrosarcoma .k 3035 to 3639 623 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 605/613
(98 %)
0 diff
(100 %id)
AW970693   .k 3190 to 3638 449 to 1     Submitted on the opposite strand 449/585
(76 %)
0 diff
(100 %id)
AW081484 colon, moderately differentiated adenocarcinoma .k 3239 to 3649 425 to 16   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 410/410
(100 %)
1 diff
(99.8 %id)
AI823336 Kidney .k 3385 to 3654 270 to 1   tiling clone,   270/270
(100 %)
0 diff
(100 %id)
NM_001164753.1   .l 1 to 3495 1 to 3495 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 3495/3495
(100 %)
0 diff
(100 %id)
DC412095 kidney, tumor tissue .l 18 to 589 1 to 572   tiling clone,   572/572
(100 %)
0 diff
(100 %id)
AK295528 hippocampus .l 38 to 1295 1 to 1260 exact tiling clone,   1260/1260
(100 %)
2 diff
(99.9 %id)
DC331071 hippocampus .l 38 to 583 1 to 547       547/547
(100 %)
1 diff
(99.9 %id)
AL596518 human spinal cord .l 38 to 396 1 to 359       359/359
(100 %)
1 diff
(99.8 %id)
DA212831 brain .l 60 to 346 2 to 289   capped   288/288
(100 %)
1 diff
(99.7 %id)
BI550799 brain, hippocampus .l 86 to 678 1 to 595       595/596
(99 %)
22 diff
(96.4 %id)
AV753931 pituitary tumor .l 173 to 747 1 to 566       570/584
(97 %)
12 diff
(98.0 %id)
AV755178 pituitary tumor .l 193 to 747 1 to 546       550/568
(96 %)
13 diff
(97.8 %id)
AV753734 pituitary tumor .l 197 to 743 1 to 537       541/557
(97 %)
11 diff
(98.1 %id)
DC343443 thalamus .m 1 to 561 1 to 561   tiling clone,   561/561
(100 %)
1 diff
(99.9 %id)
BX111251 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .m 427 to 910 1 to 484   tiling clone,   484/484
(100 %)
0 diff
(100 %id)
AI275398 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .m 478 to 991 513 to 1   tiling clone,   513/515
(99 %)
2 diff
(99.7 %id)
NM_020164.4   .n 1 to 3272 1 to 3272 exact RefSeq, AAA   3272/3272
(100 %)
0 diff
(100 %id)
AF224469 heart .n 76 to 995 1 to 920 exact tiling clone, AAA   920/920
(100 %)
0 diff
(100 %id)
AF184241 heart .n 121 to 1365 1 to 1254 exact tiling clone,   1254/1254
(100 %)
13 diff
(99.0 %id)
AA662050 alveolar rhabdomyosarcoma .n 1734 to 1979 248 to 3   tiling clone,   246/248
(99 %)
0 diff
(100 %id)
C03779 heart .n 1821 to 2074 1 to 255   tiling clone,   255/255
(100 %)
1 diff
(99.7 %id)
C03834 heart .n 1821 to 2074 1 to 254       254/254
(100 %)
4 diff
(98.5 %id)
BX499725 Liver .n 1905 to 2529 1 to 625       625/625
(100 %)
9 diff
(98.6 %id)
Z28542 leg muscle, skeletal muscle .n 2023 to 2249 1 to 227   tiling clone,   227/237
(95 %)
1 diff
(99.6 %id)
Z19214 leg muscle, skeletal muscle .n 2096 to 2406 1 to 311   tiling clone,   311/312
(99 %)
1 diff
(99.7 %id)
AA195686 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n 2122 to 2617 1 to 496   tiling clone,   496/496
(100 %)
7 diff
(98.6 %id)
BF126256 Liver .n 2353 to 3022 1 to 657       657/871
(75 %)
24 diff
(97.3 %id)
BX500438 Liver .n 2501 to 3171 1 to 672   tiling clone,   672/672
(100 %)
5 diff
(99.3 %id)
BX500444 Liver .n 2501 to 3116 1 to 617       617/617
(100 %)
4 diff
(99.4 %id)
BX500470 Liver .n 2593 to 3302 1 to 710   tiling clone,   710/710
(100 %)
3 diff
(99.6 %id)
BX102882 heart .n 2692 to 3272 1 to 581   tiling clone, AAA   581/581
(100 %)
0 diff
(100 %id)
AA284266 heart .n 2692 to 3211 1 to 520     Submitted on the opposite strand 520/520
(100 %)
2 diff
(99.7 %id)
AF086211   .n 2692 to 3272 591 to 11     Submitted on the opposite strand 581/591
(98 %)
0 diff
(100 %id)
W25631 heart .n 2692 to 3245 1 to 567       567/591
(95 %)
20 diff
(96.7 %id)
AI761723 pooled .n 2727 to 3183 461 to 5       457/461
(99 %)
0 diff
(100 %id)
BF575682 muscle (skeletal) .n 2783 to 3513 1 to 711   tiling clone,   711/848
(83 %)
32 diff
(96.3 %id)
AI338905 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n 2796 to 3272 477 to 1       477/477
(100 %)
0 diff
(100 %id)
AI252668 pooled .n 2798 to 3272 475 to 1       475/475
(100 %)
0 diff
(100 %id)
AA195687 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .n 2803 to 3272 472 to 1       472/472
(100 %)
5 diff
(99.0 %id)
AA977578 pooled .n 2803 to 3272 470 to 2       469/470
(99 %)
0 diff
(100 %id)
AI252674 pooled .n 2830 to 3272 443 to 1       443/443
(100 %)
0 diff
(100 %id)
F33848 pectoral muscle (after mastectomy) .n 2832 to 3272 1 to 441   AAA   441/441
(100 %)
19 diff
(95.7 %id)
W02677 heart .n 2842 to 3272 441 to 3       439/443
(99 %)
0 diff
(100 %id)
AW274514 pooled .n 2848 to 3272 427 to 3       425/427
(99 %)
0 diff
(100 %id)
Z19215 leg muscle, skeletal muscle .n 2951 to 3272 323 to 1       323/326
(99 %)
7 diff
(97.9 %id)
AA954311 pooled .n 3014 to 3264 260 to 9       252/260
(96 %)
0 diff
(100 %id)
NM_032467.3   .o 1 to 3227 1 to 3227 exact RefSeq, AAA   3227/3227
(100 %)
0 diff
(100 %id)
AF224468 heart .o 57 to 905 7 to 855 exact tiling clone,   849/855
(99 %)
5 diff
(99.5 %id)
AL599973   .o 663 to 1240 1 to 580   tiling clone,   580/582
(99 %)
10 diff
(98.3 %id)
NM_001164756.1   .p 1 to 1694 1 to 1694 exact RefSeq, AAA   1694/1694
(100 %)
0 diff
(100 %id)
DA401175 thalamus .p 3 to 574 2 to 573   tiling clone, capped   572/572
(100 %)
2 diff
(99.7 %id)
BI916990 brain .p 3 to 667 1 to 666       666/667
(99 %)
7 diff
(99.0 %id)
TI_57239387   .p 3 to 667 31 to 696       666/697
(95 %)
9 diff
(98.8 %id)
DA793083 brain .p 33 to 538 2 to 507   capped   506/506
(100 %)
2 diff
(99.7 %id)
DA182856 amygdala .p 34 to 579 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA658382   .p 35 to 604 2 to 571   capped   570/570
(100 %)
3 diff
(99.5 %id)
TI_57240706   .p 41 to 790 27 to 777       751/777
(96 %)
12 diff
(98.5 %id)
BI914705 brain .p 46 to 790 1 to 745       745/745
(100 %)
8 diff
(99.0 %id)
DA130005 alzheimer cortex .p 54 to 680 2 to 628   capped   627/627
(100 %)
2 diff
(99.7 %id)
TI_45214471   .p 66 to 762 122 to 818       697/818
(85 %)
8 diff
(99.1 %id)
BI601099 brain, hypothalamus .p 70 to 762 1 to 693       693/693
(100 %)
11 diff
(98.5 %id)
BI544993 brain, hippocampus .p 88 to 831 1 to 745       745/745
(100 %)
9 diff
(98.8 %id)
BI545152 brain, hippocampus .p 88 to 772 1 to 685       685/685
(100 %)
8 diff
(98.9 %id)
AL532808 adult brain, brain .p 94 to 1032 1 to 930 exact fully sequenced,   930/930
(100 %)
4 diff
(99.6 %id)
TI_44000948   .p 94 to 831 93 to 831       739/831
(88 %)
7 diff
(99.2 %id)
TI_44001198   .p 94 to 772 88 to 766       679/766
(88 %)
6 diff
(99.3 %id)
BI553296 brain, hippocampus .p 100 to 646 1 to 547   available from MGC,   547/547
(100 %)
6 diff
(99.0 %id)
BI550648 brain, hippocampus .p 100 to 801 1 to 700       700/999
(70 %)
18 diff
(98.2 %id)
BI825070 pooled brain, lung, testis .p 104 to 833 28 to 755       728/755
(96 %)
10 diff
(98.7 %id)
BI756754 brain .p 104 to 855 1 to 768       768/1043
(73 %)
35 diff
(96.7 %id)
TI_57201618   .p 104 to 833 28 to 755       728/755
(96 %)
10 diff
(98.7 %id)
BC066929 Brain, hippocampus .p 105 to 1697 1 to 1593 exact tiling clone, available from MGC, AAA   1593/1593
(100 %)
3 diff
(99.9 %id)
TI_44170305   .p 105 to 646 91 to 632       542/632
(85 %)
6 diff
(99.1 %id)
BM544647 brain, hippocampus .p 106 to 989 1 to 883 exact tiling clone,   883/1040
(84 %)
9 diff
(99.2 %id)
BM544377 brain, hippocampus .p 106 to 988 21 to 902 exact     882/1073
(82 %)
13 diff
(98.8 %id)
TI_57216705   .p 106 to 855 38 to 803       766/1078
(71 %)
35 diff
(96.8 %id)
BC142967 Clones donated by RIKEN .p 124 to 1694 1 to 1571 exact AAA   1571/1571
(100 %)
4 diff
(99.8 %id)
BG705373 brain, hippocampus .p 130 to 757 1 to 629       629/629
(100 %)
13 diff
(98.0 %id)
TI_1948207607   .p 266 to 668 130 to 532       403/427
(94 %)
6 diff
(98.6 %id)
TI_1948207854   .p 266 to 710 134 to 578       445/469
(94 %)
6 diff
(98.8 %id)
TI_1948207855   .p 266 to 890 744 to 118 R4C K5N A7C K8Q S9E ...     627/1306
(48 %)
11 diff
(99.2 %id)
TI_1948208121   .p 266 to 823 128 to 689       562/1250
(44 %)
32 diff
(97.5 %id)
TI_1948208122   .p 266 to 889 136 to 759 E173D Q186H D199E L200F     624/1409
(44 %)
18 diff
(98.8 %id)
TI_1948208373   .p 266 to 658 127 to 519       393/417
(94 %)
6 diff
(98.6 %id)
TI_1948208374   .p 266 to 741 134 to 609       476/500
(95 %)
6 diff
(98.8 %id)
EL734172 mixed .p 270 to 890 1 to 621 exact     621/680
(91 %)
6 diff
(99.2 %id)
TI_1948208123   .p 362 to 890 656 to 121       536/1243
(43 %)
26 diff
(98.0 %id)
TI_1948207856   .p 371 to 890 636 to 117       520/578
(89 %)
0 diff
(100 %id)
TI_1948208124   .p 376 to 890 636 to 120       517/534
(96 %)
2 diff
(99.7 %id)
TI_1948207609   .p 392 to 890 616 to 114       503/1423
(35 %)
25 diff
(98.3 %id)
TI_1948208376   .p 412 to 890 599 to 121       479/496
(96 %)
0 diff
(100 %id)
BY796276 eye .p 497 to 1078 1 to 582       582/582
(100 %)
0 diff
(100 %id)
EL954801 eyeball .p 598 to 1061 15 to 478       464/478
(97 %)
6 diff
(98.8 %id)
BQ720479 sympathetic trunk .p 716 to 1226 1 to 516       516/999
(51 %)
25 diff
(97.5 %id)
BF356940 head_neck .p 782 to 1147 370 to 1       370/370
(100 %)
6 diff
(98.4 %id)
AL564977 adult brain, brain .p 1002 to 1655 649 to 1   fully sequenced,   649/649
(100 %)
30 diff
(95.4 %id)
D61463   .p 1151 to 1360 1 to 211       211/211
(100 %)
2 diff
(99.1 %id)
DB568128 hypothalamus .p 1204 to 1694 1 to 490     Submitted on the opposite strand 490/490
(100 %)
1 diff
(99.8 %id)
DB540425 hippocampus .p 1214 to 1696 1 to 483     Submitted on the opposite strand 483/484
(99 %)
1 diff
(99.8 %id)
DB536126 hippocampus .p 1232 to 1694 1 to 462     Submitted on the opposite strand 462/462
(100 %)
5 diff
(99.0 %id)
DB553404 hypothalamus .p 1247 to 1693 1 to 448     Submitted on the opposite strand 448/449
(99 %)
2 diff
(99.6 %id)
DB553302 hypothalamus .p 1252 to 1693 1 to 443     Submitted on the opposite strand 443/444
(99 %)
2 diff
(99.6 %id)
DB535316 hippocampus .p 1268 to 1692 1 to 424     Submitted on the opposite strand 424/426
(99 %)
9 diff
(97.9 %id)
DB566504 hypothalamus .p 1270 to 1693 1 to 424     Submitted on the opposite strand 424/425
(99 %)
1 diff
(99.8 %id)
DB533345 hippocampus .p 1282 to 1694 1 to 416     Submitted on the opposite strand 416/416
(100 %)
7 diff
(98.4 %id)
DB533607 hippocampus .p 1288 to 1693 1 to 408     Submitted on the opposite strand 408/409
(99 %)
17 diff
(95.9 %id)
DB562895 hypothalamus .p 1289 to 1698 1 to 411   tiling clone, Submitted on the opposite strand 411/411
(100 %)
2 diff
(99.6 %id)
DB529565 hippocampus .p 1400 to 1693 9 to 304     Submitted on the opposite strand 296/304
(97 %)
8 diff
(97.4 %id)
Z38391 brain, total brain .p 1467 to 1684 226 to 9       218/226
(96 %)
0 diff
(100 %id)
BQ720541 sympathetic trunk .p 1561 to 1694 1 to 134   AAA   134/134
(100 %)
0 diff
(100 %id)
DC404182 testis .q 1 to 587 1 to 588 A87C P88S E90* tiling clone,   588/588
(100 %)
1 diff
(99.9 %id)
DA132284 alzheimer cortex .r 1 to 561 2 to 562   tiling clone, capped   561/561
(100 %)
1 diff
(99.9 %id)
BU502606 carcinoma, cell line, Prostate .r 381 to 1186 8 to 819   tiling clone,   813/911
(89 %)
14 diff
(98.5 %id)
BM759619 Ascites, stomach .r 682 to 1226 1 to 544       544/544
(100 %)
5 diff
(99.1 %id)
TI_159696588   .r 870 to 1592 796 to 77   tiling clone, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 720/992
(72 %)
6 diff
(99.4 %id)
BU618198 Cell Line, Chondrosarcoma .r 888 to 1596 727 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 709/709
(100 %)
3 diff
(99.6 %id)
TI_154057749   .r 926 to 1729 885 to 93       793/1001
(79 %)
26 diff
(97.5 %id)
CA419323 Bone, Human Chondrosarcoma Cell Line .r 972 to 1728 776 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 758/758
(100 %)
2 diff
(99.8 %id)
CA423433 cell lines, Chondrosarcoma .r 976 to 1728 772 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 754/754
(100 %)
1 diff
(99.9 %id)
BU633420 cell lines, Chondrosarcoma .r 979 to 1728 769 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 751/751
(100 %)
1 diff
(99.9 %id)
BX104648 colon .r 1108 to 1728 1 to 622   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 622/622
(100 %)
2 diff
(99.7 %id)
CA419357 Bone, Human Chondrosarcoma Cell Line .r 1138 to 1729 610 to 18   tiling clone,   593/612
(96 %)
0 diff
(100 %id)
BU622223 Cell Line, Chondrosarcoma .r 1138 to 1728 610 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 592/592
(100 %)
1 diff
(99.9 %id)
BM785369 Ascites, stomach .r 1149 to 1721 1 to 574       574/574
(100 %)
2 diff
(99.7 %id)
BM747035 Ascites, stomach .r 1149 to 1619 1 to 472       472/472
(100 %)
3 diff
(99.4 %id)
AW963683   .r 1160 to 1727 573 to 1     Submitted on the opposite strand 573/616
(93 %)
15 diff
(97.6 %id)
AA543030 colon .r 1197 to 1729 537 to 6   tiling clone,   532/552
(96 %)
0 diff
(100 %id)
BM745431 Ascites, stomach .r 1207 to 1432 1 to 229       229/229
(100 %)
4 diff
(98.3 %id)
BQ000894 lung, Metastatic Chondrosarcoma .r 1248 to 1728 503 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 485/485
(100 %)
7 diff
(98.6 %id)
AA374184 lung .r 1551 to 1729 188 to 10     Submitted on the opposite strand 179/188
(95 %)
0 diff
(100 %id)
BQ722578 sympathetic trunk .s 1 to 899 1 to 909 P169S V170C E171G E172R Q173T ... tiling clone,   909/920
(98 %)
36 diff
(96.1 %id)
BG715233 brain, hypothalamus .t 1 to 754 7 to 765 H9Q G10W G11R H12T K13Q ... tiling clone,   765/926
(82 %)
41 diff
(95.6 %id)
BM724578 eye, fetal eye .t 36 to 541 1 to 505   tiling clone,   505/505
(100 %)
1 diff
(99.9 %id)
BU741737 eye, fetal eye .t 786 to 1460 694 to 19   tiling clone, AAA   676/676
(100 %)
2 diff
(99.8 %id)
DA317421 hippocampus .u 1 to 561 2 to 562 exact tiling clone, capped   561/561
(100 %)
0 diff
(100 %id)
BM785890 Ascites, stomach .va 1 to 536 1 to 536 exact tiling clone,   536/536
(100 %)
0 diff
(100 %id)
CR600401 adult brain .vb 1 to 1565 1 to 1565 exact tiling clone,   1565/1565
(100 %)
0 diff
(100 %id)
T26989   .vb 192 to 550 1 to 359       359/361
(99 %)
8 diff
(97.8 %id)
BE089554 breast .vb 277 to 539 291 to 29     Submitted on the opposite strand 263/386
(68 %)
0 diff
(100 %id)
T26988   .vb 1349 to 1604 256 to 1   tiling clone,   256/256
(100 %)
2 diff
(99.3 %id)
BG764268 melanotic melanoma, high MDR (cell line), skin .vc 1 to 848 1 to 850 A47S P48S K49* tiling clone,   850/853
(99 %)
14 diff
(98.4 %id)
TI_57242822   .vd 1 to 755 32 to 788 E114D N123T tiling clone,   757/981
(77 %)
17 diff
(98.3 %id)
DA136318 alzheimer cortex .ve 1 to 627 2 to 628 exact tiling clone, capped   627/627
(100 %)
0 diff
(100 %id)
DA756906   .ve 22 to 560 2 to 541   capped   540/548
(98 %)
2 diff
(99.7 %id)
DB449850 testis .ve 28 to 560 1 to 552       549/696
(78 %)
51 diff
(92.7 %id)
TI_57199095   .ve 28 to 910 51 to 938 C116V     888/951
(93 %)
25 diff
(97.4 %id)
BI822264 pooled brain, lung, testis .ve 34 to 910 1 to 882 C116V tiling clone,   882/895
(98 %)
21 diff
(97.7 %id)
CB989329 Human Placenta, placenta .ve 70 to 566 29 to 529       501/1156
(43 %)
21 diff
(98.2 %id)
CX873202 embryonic stem .ve 77 to 657 1 to 800 G108E K109T Y110K T111H F112G ...     599/800
(74 %)
12 diff
(98.5 %id)
BG332543 large cell carcinoma, lung .ve 101 to 560 1 to 459       459/866
(53 %)
11 diff
(98.8 %id)
DR421666 eye, Pterygium .ve 339 to 999 59 to 717   tiling clone, AAA   659/717
(91 %)
7 diff
(99.1 %id)
BU158234 epidermoid carcinoma, cell line, salivary gland .vf 1 to 783 1 to 784 exact tiling clone,   784/788
(99 %)
5 diff
(99.4 %id)
BQ936302 carcinoma, cell line, Prostate .vf 11 to 699 23 to 718 A7G S13X S20T D102G A103W ...     696/1002
(69 %)
25 diff
(97.6 %id)
BU542964 carcinoma, cell line, Prostate .vf 13 to 801 1 to 789 S20T     789/793
(99 %)
6 diff
(99.3 %id)
BU543358 carcinoma, cell line, Prostate .vf 13 to 782 1 to 770 S20T tiling clone, AAA   770/770
(100 %)
1 diff
(99.9 %id)
BU552409 carcinoma, cell line, Prostate .vf 13 to 762 1 to 755 S10I S16M G17R S18L G19R ...     755/970
(77 %)
59 diff
(94.0 %id)
CN368820 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .vf 27 to 792 1 to 767 exact tiling clone,   767/767
(100 %)
2 diff
(99.8 %id)
AI652752 pooled germ cell tumors .vf 217 to 795 581 to 3 exact     579/581
(99 %)
0 diff
(100 %id)
BQ775731 Bone, Human Chondrosarcoma Cell Line .vf 318 to 788 483 to 13   AAA   471/525
(89 %)
3 diff
(99.5 %id)
TI_149304316   .vf 324 to 797 138 to 614     Submitted on the opposite strand 477/1014
(47 %)
13 diff
(98.8 %id)
BU685263 lung, Primary Lung Epithelial Cells .vf 324 to 781 54 to 513     Submitted on the opposite strand 460/495
(92 %)
7 diff
(98.6 %id)
TI_149280946   .vf 331 to 787 128 to 586     Submitted on the opposite strand 459/766
(59 %)
8 diff
(99.0 %id)
BU679486 lung, Primary Lung Epithelial Cells .vf 331 to 726 61 to 458     Submitted on the opposite strand 398/440
(90 %)
6 diff
(98.7 %id)
AI915992 colon, colon tumor, RER+ .vf 467 to 787 327 to 5       323/487
(66 %)
3 diff
(99.4 %id)
CB157740 Liver .vf 480 to 676 1 to 197       197/197
(100 %)
5 diff
(97.5 %id)
CB121339 Liver .vf 554 to 782 1 to 227   AAA   227/227
(100 %)
2 diff
(99.2 %id)
DA409019 thalamus .vg 1 to 662 2 to 663 exact tiling clone, capped   662/662
(100 %)
0 diff
(100 %id)
DA882800   .vh 1 to 547 2 to 549 exact tiling clone, capped   548/548
(100 %)
1 diff
(99.9 %id)
BF374990 stomach .vi 1 to 338 1 to 338 V12I E13K F18L tiling clone,   338/343
(98 %)
11 diff
(96.8 %id)
BF576214 muscle (skeletal) .vj-u 1 to 724 1 to 717   tiling clone,   717/820
(87 %)
40 diff
(95.2 %id)
BF196979 pooled .vj-u 358 to 860 521 to 19   tiling clone, AAA   503/503
(100 %)
0 diff
(100 %id)
AI808211 pooled .vj-u 447 to 865 419 to 1       419/419
(100 %)
5 diff
(98.9 %id)
DA625020 Kidney .vj-u 578 to 1140 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
BG611398 adenocarcinoma, Prostate .vj-u 709 to 1453 1 to 744   tiling clone,   744/745
(99 %)
8 diff
(99.0 %id)
BG503988 embryonal carcinoma, testis .vj-u 768 to 1406 1 to 641   tiling clone,   641/641
(100 %)
4 diff
(99.4 %id)
R79767 placenta .vj-u 888 to 1268 1 to 393       393/410
(95 %)
18 diff
(95.7 %id)
CN313105 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .vj-u 1433 to 2195 1 to 764 exact tiling clone,   764/764
(100 %)
5 diff
(99.4 %id)
AA906160 pooled .vj-u 1617 to 2008 406 to 15 G35A     392/406
(96 %)
0 diff
(100 %id)
AA929005 pooled .vj-u 1923 to 2127 1 to 208     Submitted on the opposite strand 208/208
(100 %)
6 diff
(97.2 %id)
DB320584 Kidney .vj-u 1986 to 2544 559 to 1   tiling clone,   559/564
(99 %)
1 diff
(99.9 %id)
TI_159723081   .vj-u 2045 to 2544 578 to 79   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 500/1036
(48 %)
6 diff
(99.5 %id)
CA944879 Human Lung Epithelial cells, lung .vj-u 2045 to 2563 518 to 1       518/518
(100 %)
8 diff
(98.5 %id)
DB280966 uterus .vj-u 2106 to 2670 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
BX503007 Liver .vj-u 2447 to 2955 1 to 511   tiling clone,   511/511
(100 %)
3 diff
(99.5 %id)
BE784594 large cell carcinoma, lung .vj-u 2546 to 3329 1 to 794   tiling clone,   794/1101
(72 %)
31 diff
(97.2 %id)
DB285929 uterus .vj-u 2551 to 3087 2 to 538   tiling clone, capped   537/537
(100 %)
0 diff
(100 %id)
AI693329 carcinoid, lung .vj-u 3150 to 3695 558 to 13   tiling clone, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 546/546
(100 %)
1 diff
(99.9 %id)
AW935920 denis_drash .vk-u 1 to 321 6 to 327   tiling clone,   327/327
(100 %)
3 diff
(99.1 %id)
CV403255 breast .vk-u 112 to 623 1 to 515   tiling clone,   515/527
(97 %)
17 diff
(96.8 %id)
BF742727 breast .vk-u 149 to 623 4 to 480       477/492
(96 %)
9 diff
(98.2 %id)
BF742721 breast .vk-u 196 to 623 4 to 433       430/441
(97 %)
10 diff
(97.8 %id)
BX954824   .vk-u 513 to 941 1 to 429 exact tiling clone,   429/429
(100 %)
0 diff
(100 %id)
CV570054 cornea, eye .vl-u 313 to 881 1 to 569   tiling clone,   569/569
(100 %)
0 diff
(100 %id)
BG697450 skin .vm 1 to 750 1 to 749 F22L V23* tiling clone,   749/777
(96 %)
6 diff
(99.3 %id)
BX502927 Liver .vn-u 1 to 719 1 to 720 exact tiling clone,   720/720
(100 %)
4 diff
(99.5 %id)
CD357382 Blood vessels - aorta, basilar and artery .vo-u 1 to 645 1 to 656 V37A tiling clone,   656/804
(81 %)
27 diff
(96.7 %id)
DW440458 Liver .vp-u 1 to 371 17 to 387 exact tiling clone,   371/387
(95 %)
6 diff
(98.5 %id)
AI827880 pooled .vq 1 to 329 329 to 1 exact tiling clone,   329/329
(100 %)
3 diff
(99.1 %id)
FN158082 breast carcinoma .vr-u 1 to 101 1 to 105 D8G W9L S10E Q11P F12V ... tiling clone,   105/109
(96 %)
6 diff
(94.5 %id)
BX486557   Gene ASPH, variant not shown              
226 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf, .vg, .vh, .vi, .vj-u, .vk-u, .vl-u, .vm, .vn-u, .vo-u, .vp-u, .vq, .vr-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI